Elisa Cordero - Infectious Diseases

Author Information

Elisa Cordero is affiliated with the Instituto de Biomedicina de Sevilla (IBIS), University Hospital Virgen del Rocío/CSIC/University of Sevilla, within the Unit of Infectious Diseases, Microbiology, and Preventive Medicine in Spain. Her research primarily focuses on infectious diseases, with a special interest in the implications and treatments of infections in immunocompromised patients, such as kidney transplant recipients, and the impact of COVID-19.

Research Contributions

Elisa Cordero has made significant contributions to the field of infectious diseases, particularly in the context of kidney transplant recipients and COVID-19. Her work includes studies on the persistence of dendritic cell deficiencies following SARS-CoV-2 infection, the treatment of asymptomatic bacteriuria in kidney transplant recipients, and the impact of early post-transplant infections on COVID-19 outcomes. Additionally, she has researched the efficacy of various antibiotics and treatment protocols for infections in immunocompromised patients, exploring the nuances of bacterial resistance and treatment safety.

Aliases

Elisa Cordero is also known by the aliases E Cordero and E. Cordero in various publications.

Publication and Citation Metrics

Metric	Value
Total Papers	129
Citation Count	3961
H-Index	37

Publications:

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

DOI: 10.1038/s41423-021-00728-2

Year: 2021

Impact of Treating Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Prospective Cohort Study

DOI: 10.3390/antibiotics10020218

Year: 2021

Efficacy and Safety of Oral Fosfomycin for Asymptomatic Bacteriuria in Kidney Transplant Recipients: Results from a Spanish Multicenter Cohort

DOI: 10.1128/AAC.02267-20

Year: 2021

Variations in the number of human permanent teeth: Hypodontia

DOI:

Year: 2021

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

DOI: 10.1371/journal.pone.0250796

Year: 2021

Propensity Score and Desirability of Outcome Ranking Analysis of Ertapenem for Treatment of Nonsevere Bacteremic Urinary Tract Infections Due to Extended-Spectrum-Beta-Lactamase-Producing Enterobacterales in Kidney Transplant Recipients

DOI: 10.1128/AAC.01102-21

Year: 2021

Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing Enterobacterales in kidney transplant recipients: a propensity score and DOOR-based analysis.

DOI: 10.1128/AAC.01102-21

Year: 2021

Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study)

DOI: 10.1016/j.opresp.2021.100086

Year: 2021

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

DOI: 10.1038/s41598-021-92400-y

Year: 2021

Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients

DOI: 10.1111/ajt.16503

Year: 2021

What are Muscle Aches?

Why is MRI Important?

What Are the Common Symptoms of Immunodeficiency Disorders?

What are the Key Components of HTS?

What is the Significance of Structural Protein Mutations?

How Does Lipid Metabolism Influence Pathogen Resistance?

Can Respiratory Symptoms Be Prevented?

What are Influenza Antivirals?

Why Is Aedes Aegypti So Efficient at Spreading Diseases?

How is HFMD Transmitted?

Partnered Content Networks

Relevant Topics